Page 36 - CPG - Clinical Practice Guidelines - Management of Cancer Pain
P. 36
Management of Cancer Pain (Second Edition)
R[\FRGRQH ZLWKLQ RQH KRXU RI LQJHVWLRQ DQG DQ DQDOJHVLF GXUDWLRQ RI
hours. 36, level III
)HQWDQ\O
Fentanyl is an alternative opioid that can be used in cancer pain. In
Malaysia, it is available as transdermal patch, sublingual and parenteral
preparations.
Transdermal (TD) fentanyl should only be considered in patients with
VWDEOH RSLRLG UHTXLUHPHQWV ZKR KDYH GLI¿FXOW\ VZDOORZLQJ RU LQWUDFWDEOH
9
nausea and vomiting. In a Cochrane systematic review comparing
TD fentanyl with oral morphine for relief of cancer pain, there was
LQVXI¿FLHQW FRPSDUDEOH GDWD IRU D PHWD DQDO\VLV WR EH XQGHUWDNHQ
for the analgesic effect. However, transdermal fentanyl showed a
reduction in constipation (RR=0.61, 95% CI 0.47 to 0.78; NNT=5.5). No
meaningful analysis was possible for other AEs. 37, level I
When switching from other opioids to transdermal fentanyl, there is a
lag time between application of the patch and onset of analgesia due to
its pharmacokinetics whereby on average, minimally effective plasma
concentrations of fentanyl are seen in 12 hours. Regular 4-hourly
oral opioids should therefore, be discontinued 12 hours after patch
DSSOLFDWLRQ 6LPLODUO\ ZKHQ FRQYHUWLQJ IURP 65 RSLRLG SUHSDUDWLRQV WKH
9
SDWFK VKRXOG EH DSSOLHG WRJHWKHU ZLWK WKH ODVW GRVH RI 65 PHGLFDWLRQ
However, an RCT on the conversion of IV to transdermal fentanyl in
chronic cancer pain revealed that the effectiveness of continuing the IV
IRU VL[ KRXUV DIWHU SDWFK DSSOLFDWLRQ K PHWKRG ZDV HTXLYDOHQW WR WKH
12-h method in terms of number of rescue doses for breakthrough pain
required (p>0.05) and thus may be considered for a simpler method of
conversion. 38, level I
7KH 7PD[ RI WUDQVGHUPDO IHQWDQ\O LV KRXUV DQG WKH GXUDWLRQ RI
action is 72 hours. The plasma half-life of transdermal fentanyl ranges
IURP KRXUV 3DUHQWHUDO IHQWDQ\O H J EROXVHV RI ,9 6& KDV D
VKRUW GXUDWLRQ RI DFWLRQ RI DSSUR[LPDWHO\ PLQXWHV DQG LV QRW URXWLQHO\
used for maintenance therapy. 34
Fentanyl is generally considered a safer opioid in renal impairment as
its metabolites have minimal effect. 39, level I
7KH DSSUR[LPDWH SKDUPDFRNLQHWLF SDUDPHWHUV RI PRUSKLQH R[\FRGRQH
and fentanyl are shown in Table 3.
18
e-cpg inside text-Cancer pain-25/5/24.indd 18 09/08/2024 12:09 AM